Blood markers in diabetic heart attack patients having emergency angioplasty
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how certain blood tests differ in people with diabetes who have a severe heart attack (STEMI) and receive emergency angioplasty (primary PCI). The goal is to find markers that may help predict outcomes and guide future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a type of heart attack called STEMI (ST-segment elevation myocardial infarction) and are being treated with emergency angioplasty (primary PCI).
- You have diabetes.
- You have not had a prior heart procedure such as angioplasty (PCI) or bypass surgery (CABG).
- You have not received clot-busting drugs (thrombolytics) or other anti-clotting medications before arriving at the hospital.
- You do not have a blood disorder (like thalassemia, myelodysplastic syndrome, or leukemia), active infection, autoimmune disease, cancer, severe kidney or liver disease, or recent blood transfusion.
- You are not in cardiogenic shock and have no mechanical complications of the heart attack.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether insulin resistance (when the body doesn't use insulin well) is linked to poor blood flow after a stent procedure in people with type 2 diabetes who have had a heart attack. It might help doctors understand why some people have worse outcomes after this treatment.
This study looks at people who had emergency heart catheterization (a procedure to examine heart arteries) to better understand heart disease. It may help researchers develop new ways to prevent and treat heart attacks.
This study looks at certain fats in the blood of people having a severe heart attack called STEMI. Researchers want to see if these fats can help understand what happens in the body during a heart attack.
This study is looking at certain blood markers and heart tissue changes in people who have recently had a heart attack. The goal is to understand how the heart heals and remodels after an attack, which could help improve future treatments.
This study looks at two blood markers (mean platelet volume and systemic inflammatory response index) to see if they help predict outcomes in people admitted with a heart attack or unstable angina. If you've had chest pain from a heart condition and get to the hospital quickly, this could be relevant for you.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
Hear when a new STEMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.